Analysis

4 Recent Fed. Circ. Decisions Patent Attorneys Need To Know

Law360 (April 8, 2019, 7:27 PM EDT) -- The Federal Circuit has issued rulings this year that could potentially lengthen the terms of drug patents and cast further doubt on the viability of patents on medical diagnostic tests. Here's a look at the court's most significant patent rulings since the beginning of 2019.

Supernus Pharmaceuticals Inc. v. Iancu

In this January decision, the Federal Circuit struck down U.S. Patent and Trademark Office regulations on how the patent terms are calculated, opening the door for owners of drug patents to seek potentially lucrative extensions of patent protection.

The case involved "patent term adjustment," time that is added to the life...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!